On 25 October 2018, the Court of Justice of the European Union (CJEU) handed down a judgment in Boston Scientific (C-527/17) concerning Supplementary Protection Certificates (SPCs) for medicinal products in the context of medical devices.
Following July's judgment from the Court of Justice of the EU (CJEU), Mr Justice Arnold has handed down his final decision in Teva v Gilead, finding Gilead's SPC to be invalid.
Like any evolving industry, the wind power sector has seen a spike in technological advancements in the past decade, with rival companies engaged in a race to patent innovations in different or overlapping areas of technology to gain a competitive advantage.
On September 12, the European Parliament voted to approve the revised Copyright Directive, which is intended to harmonise aspects of EU copyright law.
The new list of Top 200 Nottinghamshire companies has just been published by the Nottingham Post. It shows Potter Clarkson, which was at 149 a couple of years ago, now at 134 with our £30m turnover from 2017.
Stephen McNeeney, partner and pharmaceuticals expert, comments on the news that Orexo AB has won its patent appeal with Teva over its Zubsolv opioid addiction drug.